MedPath

Comparison of Preconditioning Effect of High Dose and Low Dose Atorvastatin Treatment in Patients Underwent CABG

Phase 4
Conditions
Coronary Artery Bypass Surgery.
Atherosclerotic heart disease
Registration Number
IRCT2017080619470N61
Lead Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

patients who had been taking (atorvastatin 20 mg daily) at least one year prior to the cardiac surgery.
Exclusion criteria:
unstable angina; evidences of recent MI (within 6 months) ; history of cardiac surgery; congenital heart disease; history of cardiac arrhythmia (arterial fibrillation) before surgery; receiving anti- arrhythmic drugs (except Beta blockers) ; having pacemaker; left ventricle ejection fraction less than 30%, uncontrolled hypertension; arterial or ventricular arrhythmia; pregnancy; patient who are undergoing diabetes treatment; increased level of liver enzymes; renal failure with creatinine more than 2 mg/dl; active inflammation or immune deficiency; positive history of muscle disease or reaction to the stations.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The serum level of CPK-MB enzymes, troponin I. Timepoint: before induction of anesthesia and 24 ,48 hours after surgery. Method of measurement: Arterial blood sample.;High-sensitivity C-reactive protein (hs-CRP) levels,. Timepoint: before induction of anesthesia and 24 ,48 hours after surgery. Method of measurement: Arterial blood sample.;Mechanical ventilation duration in the ICU. Timepoint: After arrival to the ICU. Method of measurement: Observasion.
Secondary Outcome Measures
NameTimeMethod
Glomerular filtration rate (GFR) and urine output. Timepoint: After surgery in the intensive care unit. Method of measurement: observasion.;Blood glucose. Timepoint: After surgery in the intensive care unit. Method of measurement: blood sample.
© Copyright 2025. All Rights Reserved by MedPath